Waterland sells Atos Kliniken to ICG

The exit generated returns of more than 6x money on invested capital, a source close to the situation told Unquote.

Atos Kliniken's management is to increase the size of its stake in the company as part of the deal.

Unquote sister publication Mergermarket reported in May 2021 that Atos Kliniken was expected to come to market, with Rothschild mandated to run the process. One source told Megermarket that the company generates revenues of EUR 100m and EBITDA of EUR 15m, while another said that Atos generates revenues of EUR 150m and EBITDA of EUR 20m.

The aforementioned source confirmed to Unquote that the company generates run-rate EBITDA of more than EUR 20m.

Waterland formed Atos Kliniken as a buy-and-build platform in 2016 via a spin-off from rehabilitation clinic chain Median, which the GP acquired from Advent International and Marcol Healthcare in October 2014 in a EUR 1bn deal. Median had acquired Atos Kliniken earlier in 2014. Waterland invested in Median via its fifth flagship fund, which held a final close in July 2011 on EUR 1.1bn.

Waterland carved out and merged the Atos clinics in Hamburg, Heidelberg and Braunfels to form an independent entity. Following the spin-off, Atos implemented a buy-and-build strategy to acquire further clinics and to increase its treatment offering for patients.

ICG is currently deploying equity via vehicles including ICG Europe Mid-Market Fund. The vehicle held a final close in January 2020 on EUR 1bn and makes debt and equity investments in Europe-based mid-market companies. The fund's investments include Denmark-based dental clinic chain Godt Smil.

Waterland's sale of Atos comes shortly after Hg's acquisition of a majority stake in Waterland VI portfolio company Serrela, as reported. Waterland retained a minority stake in the Germany-based financial process automation software as part of the deal.

Waterland Private Equity declined to comment.

Company
Atos Kliniken is a chain of nine orthopaedic clinics in Germany offering orthopaedic treatment and elective surgeries. The first clinic was founded in Heidelberg in 1991 and the company is now headquartered in Munich. Atos employs 1,000 staff, as well as 170 doctors, generating revenues of EUR 130m, according to a statement.

People
Waterland Private Equity – Carsten Rahlfs (managing partner).
Atos Kliniken – Martin von Hummel (CEO).
Intermediate Capital Group – Martin Preuss (managing director).

Advisers
Vendor – Rothschild (M&A); Hengeler Mueller (legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• Buyouts
• DACH
• Healthcare
• Secondary buyout
• Intermediate Capital Group
• Waterland Private Equity
• Germany